Malaria drug could hold key to treating heart disease, diabetes
School of Medicine researchers found that a malaria drug eased many symptoms of metabolic syndrome in mice. Study findings were published in the November issue of Cell Metabolism, and senior author Clay F. Semenkovich, M.D., professor of medicine and of cell biology and physiology, says funding for a clinical trial has been received.
Model can predict risk of glaucoma in patients with elevated eye pressure
Investigators at the School of Medicine have developed a model to identify patients at high risk of developing glaucoma. Their research was presented at the annual meeting of the American Academy of Ophthalmology in Las Vegas.
Scientific American honors three WUSTL neuroscientists
Three Alzheimer’s disease researchers at the School of Medicine in have been named to the 2006 Scientific American 50, an honorary list of the year’s “prime movers” in a variety of scientific disciplines.
Cole named assistant vice chancellor for children’s health
ColeF. Sessions Cole, M.D., has been appointed assistant vice chancellor for children’s health at the School of Medicine and chief medical officer at St. Louis Children’s Hospital.
Unusual drug mixture inhibits tumors in mice
School of Medicine researchers find a potential therapeutic regimen for patients with aggressive neuroendocrine tumors.
Neuroscientists awarded $14 million in 2 grants
Scientists at the School of Medicine will use $14 million in grant funds to establish or expand facilities that provide services needed for research.
Nationally recognized leader joins Siteman
A leader in cancer prevention joins Siteman Cancer Center to oversee research, education and community outreach in cancer prevention.
Ferkol to head pediatric allergy, pulmonary medicine division
Thomas Ferkol, M.D., has been named director of the Division of Allergy and Pulmonary Medicine in the Department of Pediatrics.
Getting to know you
Photo by Ray MarklinLarry J. Shapiro, M.D., and Diana Gray, M.D., talk with Shamika Ketkar and Shashikant Kulkarni, Ph.D., at the New Faculty Reception Oct. 4 at the Missouri Botanical Garden.
NSAID increases liver damage in mice carrying mutant human gene
The large globules in the liver cells on the left are characteristic of alpha-1-antitrypsin deficiency. The image on the right shows normal liver cells.Research performed at Washington University School of Medicine in St. Louis sheds light on the mechanisms that contribute to liver disease in alpha-1-AT deficiency patients. People with alpha-1-deficiency have a genetic mutation that can lead to emphysema at an early age and to liver damage. Using an experimental mouse model of the disorder, the researchers investigated the effects of a non-steroidal anti-inflammatory drug (NSAID) on liver injury.
View More Stories